Luca Bisi

855 total citations
9 papers, 207 citations indexed

About

Luca Bisi is a scholar working on Infectious Diseases, Pharmacology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Luca Bisi has authored 9 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Pharmacology and 2 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Luca Bisi's work include HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Luca Bisi is often cited by papers focused on HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Luca Bisi collaborates with scholars based in Italy and Ukraine. Luca Bisi's co-authors include Andrea Gori, Stefano Di Bella, Antonio Pesenti, Giacomo Grasselli, Vittorio Scaravilli, Laura Alagna, Michela Bombino, Nicolò Patroniti, Anna Maria Peri and Andrea Cossarizza and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and Mitochondrion.

In The Last Decade

Luca Bisi

8 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Bisi Italy	4	81	59	50	49	41	9	207
Thao Thi Ngoc Pham Vietnam	7	35 0.4×	28 0.5×	52 1.0×	21 0.4×	14 0.3×	15	201
Emily Lydon United States	9	15 0.2×	76 1.3×	66 1.3×	6 0.1×	48 1.2×	21	296
Andreas Lind Norway	11	13 0.2×	23 0.4×	70 1.4×	27 0.6×	72 1.8×	32	383
Alicia de Pablo Spain	11	23 0.3×	14 0.2×	105 2.1×	20 0.4×	28 0.7×	21	366
H Köditz Germany	8	77 1.0×	18 0.3×	98 2.0×	29 0.6×	35 0.9×	32	385
Gabriele Sales Italy	8	42 0.5×	36 0.6×	56 1.1×	16 0.3×	16 0.4×	20	198
Graciano García‐Pardo Spain	8	7 0.1×	10 0.2×	139 2.8×	24 0.5×	32 0.8×	18	244
Silvia Amadasi Italy	7	14 0.2×	74 1.3×	90 1.8×	5 0.1×	14 0.3×	15	238
Aurélien Frerou France	6	37 0.5×	31 0.5×	43 0.9×	18 0.4×	6 0.1×	16	118
Jason Arnold United States	5	19 0.2×	51 0.9×	48 1.0×	13 0.3×	13 0.3×	6	163

Countries citing papers authored by Luca Bisi

Since Specialization

Citations

This map shows the geographic impact of Luca Bisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Bisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Bisi more than expected).

Fields of papers citing papers by Luca Bisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Bisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Bisi. The network helps show where Luca Bisi may publish in the future.

Co-authorship network of co-authors of Luca Bisi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Bisi. A scholar is included among the top collaborators of Luca Bisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Bisi. Luca Bisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ricci, Elena, Stefania Piconi, Stefania Cicalini, et al.. (2025). Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics).. PubMed. 48(1). 35–45.

Antolini, Laura, Alessandro Soria, Luca Bisi, et al.. (2023). Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label randomised controlled trial – the EPCoT study. ERJ Open Research. 9(4). 181–2023. 1 indexed citations

Bisi, Luca, et al.. (2017). Attempted suicide: Study of the phenomenon in a sample of patients in the province of Modena. European Psychiatry. 41(S1). S399–S399. 1 indexed citations

Grasselli, Giacomo, Vittorio Scaravilli, Stefano Di Bella, et al.. (2017). Nosocomial Infections During Extracorporeal Membrane Oxygenation: Incidence, Etiology, and Impact on Patients’ Outcome. Critical Care Medicine. 45(10). 1726–1733. 106 indexed citations

Bella, Stefano Di, Attilio Rovelli, Alessandra Sala, et al.. (2015). Tigecycline Lock Therapy for Catheter-Related Bloodstream Infection Caused by KPC-Producing Klebsiella pneumoniae in Two Pediatric Hematological Patients. Antimicrobial Agents and Chemotherapy. 59(12). 7919–7920. 11 indexed citations

Borghi, Vanni, et al.. (2012). Absence of liver steatosis in HIV–HCV co-infected patients receiving regimens containing tenofovir or abacavir. Infection. 41(2). 425–429. 3 indexed citations

Cossarizza, Andrea, Marcello Pinti, Milena Nasi, et al.. (2011). Increased plasma levels of extracellular mitochondrial DNA during HIV infection: A new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion. 11(5). 750–755. 73 indexed citations

Nasi, Milena, Marcello Pinti, Lara Gibellini, et al.. (2010). Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV ⁺ Patients. AIDS Research and Human Retroviruses. 26(5). 553–558. 10 indexed citations

Maggiolo, Franco, Monica Airoldi, Luca Bisi, et al.. (2008). Effect of a fixed-dose combination of emtricitabine, tenofovir and efavirenz on adherence and treatment acceptability (ADONE study). Journal of the International AIDS Society. 11(Suppl 1). P167–P167. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact